SEC Filings
European Court Invalidates Enanta's Paxlovid Patent And Tosses Its Infringement Suit Against Pfizer
The Unified Patent Court ruled the '265 patent invalid, ending Enanta's infringement case covering 18 EU member states.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The Unified Patent Court ruled the '265 patent invalid, ending Enanta's infringement case covering 18 EU member states.
Earnings
The biotech still targets a third-quarter 2027 readout for its Dravet trial and says $358.8 million in cash lasts into early 2028.
SEC Filings
Houle stays on as an advisor after leaving the CFO job, with his last day set for March 31, 2027.
Earnings
Third-quarter earnings reached $1.66 a share, but operating cash flow guidance fell to $230 million to $250 million.
Earnings
Adjusted EBITDA slipped to $543 million as the realized methanol price eased, but the company guided to a higher fourth quarter.
Earnings
The drug developer says faster, bigger Phase 3 enrollment shortens its cash runway from 2029 to the fourth quarter of 2028.
Earnings
The consulting firm now guides to EBITDA of 28.0% to 28.3% of revenues before reimbursements, as third-quarter earnings reached $0.64 a share.
SEC Filings
Common stockholders backed the change by 381,373,199 votes to 2,236,551; rates and total payouts stay the same.
Earnings
Deferred revenue climbed to $397 million from $253 million at year-end, as Howmet added $5 billion to its buyback.
SEC Filings
Johnson gave up the administrative title effective October 28 and stays chief risk officer, while the role itself will not be refilled.
SEC Filings
Amazon's cloud unit grew fastest in nearly five years, but a $220 billion spending plan left trailing free cash flow at negative $42.4 billion.
Earnings
The sleep-device maker's adjusted earnings rose 14% to $2.91 a share, with more than $1.0 billion returned to holders.